Repros Therapeutics (RPRX) Files $100M Mixed Shelf
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Join SI Premium – FREE
Repros Therapeutics Inc. (NASDAQ: RPRX) filed a $100 million mixed securities shelf on form S-3 with the SEC. The company may sell common stock, preferred stock, warrants, rights and/or units.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amylyx prices $500M stock offering at $35.50 per share
- QNB Corp. prices stock offering at $42 per share on Nasdaq
- Nebius Group prices upsized $5B convertible notes offering
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
